Silicon Labs (SLAB) Form 144 Notice: Insider Plans $301K Sale

Rhea-AI Filing Summary

The filing is a Form 144 notice from an individual related to Silicon Laboratories Inc. It reports a proposed sale of 2,270 shares of Common stock through Fidelity Brokerage Services on the NASDAQ, with an aggregate market value of $301,206.53 and 32,815,310 shares outstanding for the class. The shares were acquired via an option granted on 01/28/2016 and are indicated as acquired on 08/19/2025; payment is listed as cash. The filer reports no other sales in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer.

Positive

• Clear disclosure of a proposed sale of 2,270 common shares through Fidelity, providing broker, share count, and market value details
• Acquisition origin stated: shares arose from an option granted on 01/28/2016, clarifying the nature of the holdings
• No sales in past three months reported by the filer, indicating this is not part of a pattern of frequent recent insider dispositions

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider notice of a small proposed sale of company stock via broker, no recent sales reported.

This Form 144 discloses a proposed sale of 2,270 common shares for roughly $301k using Fidelity as broker. The shares originate from an option grant dated 2016 and are to be sold in August 2025. There are no reported sales by the filer in the prior three months. For most investors, this filing is a routine compliance disclosure required when officers, directors, or affiliates plan to sell restricted or control securities publicly; it does not by itself indicate material corporate events or changes in fundamentals.

Corporate Governance Specialist

TL;DR: Compliance-focused disclosure consistent with Rule 144; no governance red flags in the notice.

The form documents the mechanics of an intended sale under Rule 144, specifying broker, share count, acquisition method (option grant), and payment. The statement that the signer does not possess undisclosed material adverse information is standard. Absent additional context—such as concurrent insider sales, executive departures, or company disclosures—this filing appears procedural rather than indicative of governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2270	301206.53	32815310	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	Option Granted - 01/28/2016	Issuer			2270	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for SLAB disclose?

The notice discloses a proposed sale of 2,270 common shares of Silicon Laboratories via Fidelity with an aggregate market value of $301,206.53 on the NASDAQ.

When were the shares acquired according to this Form 144?

The filing states the shares were acquired by an option granted on 01/28/2016 and lists the acquisition date as 08/19/2025.

Has the filer sold other SLAB securities in the past three months?

The form reports Nothing to Report for securities sold during the past three months.

Through which broker will the SLAB shares be sold?

The sale is to be executed through Fidelity Brokerage Services LLC.

What representation does the filer make about material information?

The filer represents by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.